Tudor Investment Corp ET AL Purchases Shares of 44,633 Omada Health, Inc. $OMDA

Tudor Investment Corp ET AL purchased a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) in the third quarter, HoldingsChannel reports. The institutional investor purchased 44,633 shares of the company’s stock, valued at approximately $987,000.

Several other hedge funds and other institutional investors also recently modified their holdings of OMDA. Raymond James Financial Inc. purchased a new stake in Omada Health in the second quarter valued at approximately $32,000. Strs Ohio bought a new position in Omada Health in the third quarter valued at $38,000. Rakuten Investment Management Inc. purchased a new stake in Omada Health during the third quarter valued at about $49,000. JPMorgan Chase & Co. purchased a new stake in Omada Health during the third quarter valued at about $82,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Omada Health during the third quarter worth about $95,000.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Canaccord Genuity Group reduced their price objective on Omada Health from $28.00 to $22.00 and set a “buy” rating on the stock in a research report on Friday, March 6th. JPMorgan Chase & Co. dropped their target price on Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research report on Thursday, March 12th. BMO Capital Markets cut their target price on Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Wells Fargo & Company initiated coverage on shares of Omada Health in a research report on Thursday, January 8th. They set an “equal weight” rating and a $17.00 price target on the stock. Finally, Needham & Company LLC reissued a “buy” rating and set a $28.00 price target on shares of Omada Health in a research note on Thursday, January 22nd. Eight research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $23.60.

Omada Health Trading Up 1.7%

Shares of NASDAQ:OMDA opened at $12.05 on Tuesday. The stock’s 50-day moving average price is $13.35 and its 200-day moving average price is $17.62. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $28.40. The stock has a market capitalization of $709.99 million and a P/E ratio of -70.88.

Omada Health (NASDAQ:OMDA) last released its earnings results on Thursday, March 5th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.12. The company had revenue of $75.85 million during the quarter.

Insider Buying and Selling

In other Omada Health news, CFO Steven L. Cook sold 1,884 shares of Omada Health stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $13.94, for a total value of $26,262.96. Following the transaction, the chief financial officer directly owned 200,512 shares of the company’s stock, valued at $2,795,137.28. The trade was a 0.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sean P. Duffy sold 230,479 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $15.60, for a total value of $3,595,472.40. Following the completion of the sale, the chief executive officer owned 126,644 shares of the company’s stock, valued at $1,975,646.40. The trade was a 64.54% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 277,222 shares of company stock worth $4,330,695 over the last ninety days.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.